SAN FRANCISCO, June 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY) investors who have suffered over $1 million losses to submit your losses now. A securities fraud class action has been filed and certain investors have an opportunity to lead the case.
Class Period: June 9, 2021 – May 9, 2022
Lead Plaintiff Deadline: Aug. 1, 2022
Visit: https://www.hbsslaw.com/investor-fraud/XRAY
Contact An Attorney Now: [email protected]
844-916-0895
DENTSPLY SIRONA Inc. (XRAY) Securities Fraud Class Action:
The litigation focuses on DENTSPLY’s assurances that its financial statements fairly presented in all material respects the financial condition of the company.
The complaint alleges Defendants orchestrated a scheme to inflate DENTSPLY’s revenues and earnings by manipulating its accounting for a distributor rebate program so that senior executives became eligible to receive significant cash and stock-based compensation.
Investors began to learn the truth on Apr. 19, 2022, when DENTSPLY announced that it terminated CEO Donald M. Casey Jr. and that he ceased to serve on the company’s Board of Directors, both effective immediately.
Then, on May 10, 2022, DENTSPLY announced that, following reports from several whistleblowers, its Audit Committee: (1) had commenced an internal investigation into the company’s use of incentives to sell products to distributors during the third and fourth quarter of 2021 and whether those incentives were appropriately...
A nursing home run by the family of Kim Keon-hee lost the first trial in a lawsuit seeking to cancel the National Health Insurance Service's disposition to claw back about 1.4 billion won in long-...